Pulmicort flexhaler and Weight control - a phase IV clinical study of FDA data

Summary:

Weight control is reported as a side effect among people who take Pulmicort flexhaler (budesonide), especially for people who are female, 40-49 old, also take Hydrochlorothiazide, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Weight control when taking Pulmicort flexhaler. It is created by eHealthMe based on reports of 5,396 people who have side effects when taking Pulmicort flexhaler from the FDA, and is updated regularly.

What is Pulmicort flexhaler?

Pulmicort flexhaler has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 5,527 Pulmicort flexhaler users. Check the latest studies of Pulmicort flexhaler.

What is Weight control?

Weight control is found to be associated with 1,888 drugs and 2,335 conditions by eHealthMe. Check the latest studies of Weight control.

On Jul, 23, 2026

5,396 people reported to have side effects when taking Pulmicort flexhaler.
Among them, 11 people (0.2%) have Weight control.

Could Pulmicort flexhaler cause Weight control?

Among these 11 people:

What is the gender of people who have Weight control when taking Pulmicort flexhaler? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Weight control when taking Pulmicort flexhaler? *

What are other drugs people take besides Pulmicort flexhaler? *

What are other side effects people have besides Weight control? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 45.45%
Abdominal Discomfort: 4 people, 36.36%
Bipolar Disorder (mood disorder): 4 people, 36.36%
Drug Intolerance (drug sensitivity): 4 people, 36.36%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 4 people, 36.36%
Headache (pain in head): 4 people, 36.36%
Oedema (fluid collection in tissue): 4 people, 36.36%
Multiple Allergies (allergy to multiple agents): 4 people, 36.36%
Migraine (headache): 4 people, 36.36%
Drug Hypersensitivity: 3 people, 27.27%

What are the existing conditions these people have? *

Pain: 4 people, 36.36%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 36.36%
Multiple Allergies (allergy to multiple agents): 2 people, 18.18%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 9.09%
Stress And Anxiety: 1 person, 9.09%
Migraine (headache): 1 person, 9.09%
Malaise (a feeling of general discomfort or uneasiness): 1 person, 9.09%
Infection: 1 person, 9.09%
Hypotension (abnormally low blood pressure): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort flexhaler and have Weight control?

- Check whether Weight control is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort flexhaler:

Pulmicort flexhaler (5,527 reports)

Weight control treatments and more:

Weight control (62,431 reports)

Browse all side effects of Pulmicort flexhaler:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight control:

Weight control (1,888 drugs)

Browse all the conditions that are associated with Weight control:

Weight control (2,335 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort flexhaler) and Pulmicort flexhaler (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.